- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 14 x PAM: PALMITOLEIC ACID(Non-covalent)
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
GLU.2: 9 residues within 4Å:- Chain A: Y.472, P.500, L.501, T.502, R.507, G.675, S.676, T.677, E.727
12 PLIP interactions:8 interactions with chain A, 4 Ligand-Ligand interactions- Hydrophobic interactions: A:Y.472, A:Y.472
- Hydrogen bonds: A:T.502, A:T.502, A:S.676, A:T.677, A:T.677, E.2, E.2, E.2, E.2
- Salt bridges: A:R.507
GLU.7: 9 residues within 4Å:- Chain B: Y.471, P.499, L.500, T.501, R.506, G.674, S.675, T.676, E.726
9 PLIP interactions:7 interactions with chain B, 2 Ligand-Ligand interactions- Hydrophobic interactions: B:Y.471, B:E.726
- Hydrogen bonds: B:T.501, B:T.501, B:S.675, B:T.676, E.7, E.7
- Salt bridges: B:R.506
GLU.13: 9 residues within 4Å:- Chain C: Y.472, P.500, L.501, T.502, R.507, G.675, S.676, T.677, E.727
12 PLIP interactions:4 Ligand-Ligand interactions, 8 interactions with chain C- Hydrogen bonds: E.13, E.13, E.13, E.13, C:T.502, C:T.502, C:S.676, C:T.677, C:T.677
- Hydrophobic interactions: C:Y.472, C:Y.472
- Salt bridges: C:R.507
GLU.17: 9 residues within 4Å:- Chain D: Y.471, P.499, L.500, T.501, R.506, G.674, S.675, T.676, E.726
9 PLIP interactions:7 interactions with chain D, 2 Ligand-Ligand interactions- Hydrophobic interactions: D:Y.471, D:E.726
- Hydrogen bonds: D:T.501, D:T.501, D:S.675, D:T.676, E.17, E.17
- Salt bridges: D:R.506
- 4 x CYZ: CYCLOTHIAZIDE(Non-covalent)
CYZ.3: 14 residues within 4Å:- Chain A: K.515, P.516, F.517, M.518, S.519, L.773, L.781, D.782, K.785
- Chain B: I.502, S.518, S.750, K.751, G.752
8 PLIP interactions:6 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:K.515, A:P.516, A:L.773, A:L.781, B:I.502, B:I.502
- Hydrogen bonds: A:S.519, A:D.782
CYZ.8: 14 residues within 4Å:- Chain A: I.503, S.519, S.751, K.752, G.753
- Chain B: K.514, P.515, F.516, M.517, S.518, S.775, L.780, D.781, K.784
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:I.503, A:K.752, B:K.514
- Hydrogen bonds: A:S.751, A:S.751, B:S.518, B:S.775, B:S.775
CYZ.14: 14 residues within 4Å:- Chain C: K.515, P.516, F.517, M.518, S.519, L.773, L.781, D.782, K.785
- Chain D: I.502, S.518, S.750, K.751, G.752
8 PLIP interactions:6 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:K.515, C:P.516, C:L.773, C:L.781, D:I.502, D:I.502
- Hydrogen bonds: C:S.519, C:D.782
CYZ.18: 14 residues within 4Å:- Chain C: I.503, S.519, S.751, K.752, G.753
- Chain D: K.514, P.515, F.516, M.517, S.518, S.775, L.780, D.781, K.784
8 PLIP interactions:4 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:I.503, C:K.752, D:K.514
- Hydrogen bonds: C:S.751, C:S.751, D:S.518, D:S.775, D:S.775
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.4: 3 residues within 4Å:- Chain A: F.537, I.820
- Ligands: PAM.5
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.537, A:I.820
OLC.15: 3 residues within 4Å:- Chain C: F.537, I.820
- Ligands: PAM.16
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.537, C:I.820
- 4 x 79N: (2S)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate(Non-covalent)
79N.6: 8 residues within 4Å:- Chain A: L.618, R.621, I.622, G.625, F.629
- Chain D: F.595, L.602
- Ligands: PAM.20
6 PLIP interactions:2 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:F.595, D:L.602, A:L.618, A:F.629, A:F.629
- Salt bridges: A:R.621
79N.9: 5 residues within 4Å:- Chain B: L.539, Y.544, W.547, L.602
- Ligands: PAM.11
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:L.539, B:W.547, B:W.547, B:L.602
79N.10: 8 residues within 4Å:- Chain B: F.595, L.602
- Chain C: L.618, R.621, I.622, G.625, F.629
- Ligands: PAM.11
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:F.595, B:L.602, C:L.618, C:F.629, C:F.629
- Salt bridges: C:R.621
79N.19: 5 residues within 4Å:- Chain D: L.539, Y.544, W.547, L.602
- Ligands: PAM.20
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:L.539, D:W.547, D:W.547, D:L.602
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Herguedas, B. et al., Mechanisms underlying TARP modulation of the GluA1/2-gamma 8 AMPA receptor. Nat Commun (2022)
- Release Date
- 2022-02-23
- Peptides
- Isoform Flip of Glutamate receptor 1: AC
Isoform Flip of Glutamate receptor 2: BD
Voltage-dependent calcium channel gamma-8 subunit: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
IF
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 14 x PAM: PALMITOLEIC ACID(Non-covalent)
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
- 4 x CYZ: CYCLOTHIAZIDE(Non-covalent)
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 4 x 79N: (2S)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Herguedas, B. et al., Mechanisms underlying TARP modulation of the GluA1/2-gamma 8 AMPA receptor. Nat Commun (2022)
- Release Date
- 2022-02-23
- Peptides
- Isoform Flip of Glutamate receptor 1: AC
Isoform Flip of Glutamate receptor 2: BD
Voltage-dependent calcium channel gamma-8 subunit: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
DE
IF
J - Membrane
-
We predict this structure to be a membrane protein.